Skip to contentW
Whitehawk Therapeutics, Inc.
W
WHWKWhitehawk Therapeutics, Inc. Released May 15, 2017, after the close
10-Q filed May 15, 2017, 45 days after period end · 0001564590-17-011099
Q1 2017 · 10-Q
Revenue—
Net Income-$5.00M-$5.00MN/M vs Q1 2016N/M vs Q4 2016 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
-$1.06-$1.06
N/M vs Q4 2016
Operating Income-$4,759,585N/M Operating Cash Flow-$3,929,121N/M Free Cash Flowderived-$3,931,329N/M Filing lag
ended Mar 31, 2017 · filed May 15, 2017 · 45 d after period end